|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
NEOPLASIA
From the Institut für Klinische und Molekulare
Virologie, Erlangen, Germany; Ludwig Institute for Cancer Research,
Brussels Branch, Université Catholique de Louvain, Belgium; and
Department of Clinical Hematology, Hôpital Necker, Paris, France.
Adult T-cell leukemia (ATL) is an aggressive malignancy of
CD4+ T cells caused by the human T-cell leukemia virus type
1 (HTLV-1). The viral leukemogenesis is critically dependent on its
oncoprotein Tax because the protein as well as the virus can
immortalize primary human lymphocytes to permanent growth. As a
transcriptional transactivator, Tax can stimulate the expression of
distinct cellular genes. Alterations in the expression levels of
unknown growth-relevant genes may contribute to the changed growth
properties of Tax-immortalized and leukemic cells. To identify genes
that are linked to Tax transformation and ATL leukemogenesis, this
study systematically compared the gene expression of cultured cells
from patients with acute ATL with that of stimulated peripheral blood T
lymphocytes. Several overexpressed RNAs that encode signal transduction
functions were identified. These include a dual-specific protein
phosphatase (PAC1), an interferon-inducible factor (ISG15), a basic
helix-loop-helix transcription factor (DEC-1), and the secreted
antiapoptotic chemokine I-309. The ATL cell culture supernatants
contained an antiapoptotic activity that could be specifically
inhibited by antibodies directed against I-309. Inhibition of I-309
receptor (CCR8) signaling by pertussis toxin increased the apoptosis
rate of ATL cell cultures in the presence and absence of external
apoptotic stimuli. Both the I-309-specific antiapoptotic activity and
the proapoptotic effect of inhibitors of I-309 signaling suggest the
existence of an antiapoptotic autocrine loop in ATL cells. Thus, the
overexpression of this chemokine may inhibit apoptosis in ATL cells and
could substantially contribute to their growth.
(Blood. 2001;98:1150-1159) Adult T-cell leukemia (ATL) is an aggressive
leukemic disorder of CD4+ T cells caused by the human
T-cell leukemia virus type 1 (HTLV-1).1,2 It develops in
1% to 3% of infected individuals after more than 2 decades of viral
persistence.3,4 The contribution of the virus to the
pathology of the disease is believed to involve 2 mechanisms. First,
the virus directly stimulates the proliferation of the infected T cells
independently of antigen.5 Second, the HTLV-1 infection
leads to chromosomal abnormalities and an increased mutation rate in
infected cells.6-8 In addition to its oncogenic
properties, HTLV-1 induces a chronic neurologic disorder, termed
HTLV-1-associated myelopathy or tropical spastic paraparesis
(HAM/TSP),9-11 which primarily develops in patients with a
specific HLA subtype.12
As a complex retrovirus, HTLV-1 encodes the regulatory proteins Tax and
Rex in addition to structural proteins. Rex is essential for the
expression of the viral structural proteins,13-15 and Tax acts as a transactivator of the viral promoter.16-18 In
addition, Tax influences multiple cellular functions including gene
expression and proliferation and it increases the mutation
rate.19 Several lines of evidence indicate that the HTLV-1
regulatory protein p40tax is responsible for the
leukocyte transforming features of the virus.20-23 The
growth of primary human lymphocytes conditionally immortalized by Tax
depends on Tax expression. The proliferation of these immortalized
cells was reversibly arrested in the G1 phase of the cell
cycle by suppression of tax transcription, thus demonstrating that Tax stimulates the G1-to-S phase
transition in immortalized T lymphocytes.24
The mechanism by which Tax influences G1-to-S phase
transition and the growth of transformed primary human T cells is not well understood and different Tax functions may cooperate in the stimulation of cell proliferation. This includes the property of Tax to
directly interfere with the function of cell cycle-controlling proteins.25-28 For instance, Tax inhibits the
transactivating functions of the tumor suppressor p5329,30
and activates cyclin-dependent kinases CDK4 and CDK6; these CDKs are
essential for the control of the G1 phase
progression.31,32 Tax has also been shown to interfere
with DNA repair and in this way it possibly contributes to increase the
cellular mutagenesis rate.33 Thus, also this Tax function
may be crucial for leukemogenesis. Tax-induced mutations, which
accumulate during the decades of viral persistence, might affect
growth-relevant genes and as a consequence of dysregulated signaling
result in overexpressed genes.8
Its function as a modulator of cellular transcription is believed to
play a pivotal role in the stimulation of host cell proliferation, because Tax affects the gene expression of a variety of growth-relevant genes. It activates genes encoding proto-oncogenes,34,35
the In an attempt to identify genes that are linked to Tax transformation
or ATL leukemogenesis, we systematically compared the gene expression
patterns of cultured ATL cells with normal T lymphocytes using
subtractive hybridization.48 By this approach multiple overexpressed messenger RNAs (mRNAs) coding for signal transduction proteins were identified, among them the antiapoptotic chemokine I-309.
As reported here, the ATL cell cultures secreted an antiapoptotic activity and expressed the I-309 receptor CCR8. The Fas-mediated apoptosis rate of ATL cells was significantly increased when I-309 signaling was blocked. Taken together our data provide compelling evidence for an antiapoptotic autocrine loop in ATL cells.
Cell culture and stimulation of primary human T cells
Subtractive hybridization
Northern blotting For the verification and quantification of RNA expression, Northern blot analyses were performed. Total RNA was prepared from various cells, separated (10 µg/lane) on 1% formaldehyde denaturing agarose gels, and blotted as previously described.14 For the generation of probes the cDNA inserts of pT-Adv vectors were recovered by EcoRI digestion, purified by gel electrophoresis, and extracted from the agarose gel by silica-gel particles (Qiagen, Hilden, Germany). DNA fragments were radioactively labeled with [32P]-dATP (deoxyadenosine
triphosphate) by the random priming method. The hybridized mRNA was
quantified by phosphorimaging using the BAS2000 bioimaging
analyzer (Fuji, Tokyo, Japan). Signal analysis was done using the
program TINA2.0 (Raytest, Straubenhardt, Germany).
Cell proliferation assays The antiapoptotic activity of ATL cell culture supernatants was tested using BW5147C and DO-Cep4 cells, which were treated to undergo apoptosis. These and all other apoptosis- and cell proliferation-related experiments were done in triplicate in microtiter plates. Cells (2 × 103 cells/well) were incubated with 62.5 or 250 nM apoptosis-inducing dexamethasone (DEX; Sigma) and with serial dilutions of ATL cell culture supernatants in a final volume of 200 µL. Alternatively, apoptosis was induced using cisplatin (Sigma) at final concentrations ranging from 50 pg/mL to 5 ng/mL. To selectively block I-309 receptor signaling, 2.5 ng/mL pertussis toxin (Biomol, Hamburg, Germany) was added. To test the specificity of the antiapoptotic activity in the supernatants, sodium azide-free anti-I-309 antibody (R&D Systems, Wiesbaden, Germany) or a nonspecific control antibody (anti-human CD95; Becton Dickinson, Heidelberg, Germany) was added at final concentrations ranging from 1.25 ng/mL to 5 µg/mL. Purified I-309 (30 pg/mL to 20 ng/mL) and IL-9 (25 pg/mL to 2 ng/mL)50 served as controls. To assess cell viability and activity under the conditions above, MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide; Sigma) dye assays were carried out. After 48 hours, 250 µg/mL MTT was added and cells were incubated for further 4 hours. In viable cells MTT is converted into formasan dye granules. Cells were lysed by the addition of 180 µL 0.01 N HCl in isopropanol and the formasan absorbance was determined in a microplate reader set at 630 nm. To calculate total cell survival, absorbance in the presence of ATL cell culture supernatant and DEX (ODDEX+sup) was standardized to the background (absorbance in the presence of DEX only: ODDEX), the latter being arbitrarily set 1. Additional cell survival (ACS) was determined by subtraction of the background (ODDEX).
Analysis of apoptosis One method for the detection of apoptotic cells was annexin V staining. Briefly, ATL-derived and control cells were cultured under the conditions described above in 48-well plates (4 × 103 cells/well in 400 µL). After 48 hours, the cells were harvested, washed in phosphate-buffered saline (PBS), and incubated with fluorescein isothiocyanate (FITC)-conjugated recombinant annexin V (Bendermedsystems Vienna, Austria) for 15 minutes. After staining, the cells were washed in PBS and measured by flow cytometry (FACScalibur; Becton Dickinson). Alternatively, cell death rate was measured using a modified propidium iodide (PI) staining assay, which allows the distinction between apoptotic, necrotic, and viable cells.53 Cells were treated with 25 µg/mL PI (Sigma) in 2% Triton-X100 and 0.05% sodium citrate and subjected to multiparameter flow cytometry analysis.Enzyme-linked immunosorbent assay The I-309 concentration in cell culture supernatants was determined by antigen capture enzyme-linked immunosorbent assay (ELISA) using monoclonal anti-I-309 capture and biotinylated anti-I-309 detection antibodies according to the manufacturer's recommendations (R&D Systems). Briefly, 96-well microtiter plates were coated overnight with capture antibodies. The plates were incubated with serially diluted cell culture supernatants and biotinylated anti-I-309 detection antibody (R&D Systems). A standard curve was obtained using serial dilutions of recombinant human I-309 (R&D Systems). To detect the chemokine, streptavidin-conjugated horseradish peroxidase (HRP; Zymed, San Francisco, CA) and substrate solution (H2O2:tetramethylbenzidine = 1:1; Kirkegaard & Perry Laboratories, Gaithersburg, MD) were added. After terminating the reaction with 1 M H2SO4, the optical density was determined using a microplate reader set to 540 nm and 570 nm.
Identification of differentially expressed cDNAs in ATL-derived cells Dysregulated gene expression frequently indicates or causes aberrant activation of growth-relevant signal transduction pathways. In ATL cells such changes may result from transactivation of cellular promoters mediated by viral proteins or mutagenesis or both. To identify genes linked to the malignant growth, the gene expression pattern of acute ATL cells was systematically compared with that of nontransformed normal postmitotic T lymphocytes using the PCR-based SSH. This approach resulted in the cloning of cDNAs derived from transcripts, which are overexpressed in the cultured leukemia cells. In contrast to gene array techniques,46 SSH allows the isolation of novel sequences derived from unknown genes. In total, the nucleotide sequences of 346 cDNA clones were determined. The subsequent database analysis revealed that about one third of the sequences were derived from genes involved in gene regulation and signal transduction pathways. Two sequences were novel (GenBank accession numbers AJ276510 and AJ272002) and many were homologous to uncharacterized cDNAs from the expressed sequence tag (EST) database (Table 1). A variety of cDNAs corresponded to HTLV-1 or genes that have already been shown to be up-regulated in HTLV-1-infected cells due to Tax transactivation. These included the IL-2 receptor-chain and the CDK inhibitor
p21WAF1/CIP1.38,43 The genes for the
transferrin receptor and thymosin  -4 have previously been found to
be considerably overexpressed in ATL cells.54,55 The
isolation of known HTLV-1-up-regulated genes confirmed that our
experiment had resulted in cloning of differentially expressed
sequences. To quantify the RNA expression, Northern blots were
performed with following genes selected according to their biologic
function in transcription control and cellular signaling. The basic
helix-loop-helix transcription factor DEC-1 and the tumor necrosis
factor- (TNF-)-inducible B94 protein are putatively associated
with differentiation.56,57 The dual-specific protein
phosphatase PAC1 and the interferon-induced ISG15 gene were
selected because of their contribution to cellular
signaling.58,59 Calcylin, a calcium-binding protein, is
expressed in a cell cycle-specific manner and dysregulated in various
malignancies.60 The ferritin L chain and the chemokine
I-309 play a role in cell proliferation and apoptosis control,
respectively.50,61
These expression analyses revealed that the ATL-derived JuanaW cells
contained increased mRNA levels of various transcription factor and
signal transduction genes compared to PHA-stimulated T cells
(PBMCPHA). To determine the fold overexpression of these genes, the specific radioactive signals were normalized to the GAPDH
signals. A significant to strong overexpression could be found for the
basic helix-loop-helix transcription factor DEC-1 (4-fold), the dual
specific phosphatase PAC1 (7-fold), the calcium ion-binding protein
calcyclin (3-fold), the ferritin L-subunit (3-fold), the TNF-inducible
protein B94 (3-fold), and the interferon (IFN)-induced ISG15
gene (9-fold) as well as for the antiapoptotic chemokine I-309 (more
than 40-fold) (Figures 1 and
2A). Further Northern analyses were
carried out to investigate whether the up-regulation observed in JuanaW
cells is specific for HTLV-1-infected or Tax-expressing T cells. The
RNA samples used were extracted from HTLV-1-transformed cell lines
(C91-PL, MT-2), a Tax-transformed cell line (TAXI-1), ATL cells
(HuT-102, JuanaW), HTLV
Strong overexpression of the chemokine I-309 in ATL-derived cells To discriminate whether the overexpression of I-309 was an individual feature of cultured JuanaW ATL cells or was due to its leukemic origin, permanently growing cultures from 3 other patients with acute ATL were established and checked for I-309 expression. Subsequent Northern blot analyses showed a huge overexpression of the I-309 gene in the ATL-derived cultures Champ, PaBe, JuanaW (Figure 2A), and StEd (data not shown). In contrast, I-309 transcripts could be neither observed in the acute lymphoblastic leukemia (ALL)-derived CD4+ T-cell lines HuT-78 and Jurkat nor in PHA-treated PBMCs. Two specific bands corresponding to the expected mRNA sizes of approximately 550 and 2200 bases were detected. The most abundant transcript observed corresponds to the 550-base mRNA reported to code for the I-309 polypeptide.62 The larger transcript is of unknown function. To determine whether the high amount of RNA leads to the secretion of I-309 protein, cell culture supernatants were analyzed by antigen capture ELISA. As a result, I-309 was detected at concentrations ranging from about 35 ng/mL (PaBe) to more than 180 ng/mL (Champ) (Figure 2B). The same results were obtained after more than 6 months of permanent ATL cell culture. This observation indicates that I-309 overexpression is not due to uninfected activated T cells in the ATL cell preparation. In accordance with Northern blot results (data not shown), the supernatant of TAXI-1 cells, which are transformed by transduction of the Tax gene, contained only minimal amounts of I-309. Neither HAM-derived Mondi cells nor the HTLV-1-transformed MT-2 cells produced any I-309 protein. Because both cell lines are known to express the Tax protein, this suggests that the viral protein alone cannot account for the I-309 overexpression. Yet, the analysis of the I-309 promoter sequence with the MatInspector V2.2 (http://transfac.gbf.de/index.html) program63 revealed binding sites for both CREB and nuclear factor- B (NF-B) at
upstream positions 393 bp and 272 bp, which exactly match the
corresponding consensus sequences. Because Tax can stimulate the
transcription via these sites, the transactivator may contribute to the
activation of the I-309 gene in ATL cells. Taken together, these data suggest that the production and secretion of I-309 is a
characteristic of ATL-derived cells, which is neither shared by
HAM-derived nor by other HTLV-1- and Tax-expressing T cells.
Antiapoptotic activity of ATL cell supernatants is mediated by the chemokine I-309 To analyze whether the amount of I-309 secreted into the supernatant is sufficient to exert the antiapoptotic effect,50 ATL cell culture supernatants were titrated onto mouse thymoma BW5147C cells, which had been treated to undergo apoptosis. These cells have been shown to be highly susceptible to apoptosis induction by DEX.50 The addition of supernatants from 4 different ATL cultures (Champ, PaBe, JuanaW, StEd) protected the thymoma cells from DEX-induced apoptosis in a dose-dependent manner, whereas the supernatants of MT-2 and Jurkat had no antiapoptotic effect (Figure 3A). The addition of, for example, Champ supernatant increased cell survival by up to 100% compared with cell survival in the absence of ATL culture supernatant. This is consistent with ELISA results, which showed that Champ cells expressed the largest amounts of I-309 (Figure 2B). Flow cytometric analysis of the DNA content of individual nuclei confirmed that the increased cell survival is largely due to a reduced apoptosis rate (data not shown).
To confirm that the antiapoptotic activity was mediated by the I-309 receptor, CCR8, an inhibitor was added. Pertussis toxin interferes with the CCR8-associated Gi-protein signaling. As a result, the antiapoptotic effect of the ATL cell supernatant was dramatically reduced or even completely abolished in the presence of pertussis toxin (Figure 3B). The same result could be obtained with purified I-309 (Figure 3C). These observations suggested the involvement of a Gi-protein-coupled receptor like CCR8 in this pathway and corroborated the notion that I-309 is the factor in the supernatant that had prevented apoptosis. These data could be confirmed using 2 different methods (MTT and [3H]-thymidine incorporation assays) in 2 murine cell lines (BW5147C, DO-Cep4) (Figure 3 and data not shown). Culturing both tester cells with ATL culture supernatant also increased cell survival by up to 45% in the presence of cisplatin, a DNA intercalating drug leading to strand breaks. Under these conditions, cell viability was considerably reduced by pertussis toxin (data not shown). To add further proof that the I-309 chemokine is the factor mediating the antiapoptotic activity, DEX-treated BW5147C cells were incubated with JuanaW supernatant and increasing amounts of monoclonal antibodies specific to I-309. As shown in Figure 3D, the antiapoptotic effect could be abolished by anti-I-309 antibodies in a dose-dependent manner, whereas the isotypic control antibody had no effect on the growth of the cells. Hence, the I-309 present in the ATL supernatant is capable of preventing apoptosis of T cells. Autocrine antiapoptotic activity of I-309 in an ATL cell culture contributes to cell proliferation The demonstration of the antiapoptotic activity in the ATL cell supernatant led us to the hypothesis that I-309 may act on the producer cells to increase their resistance to apoptosis. This, however, would require the presence of the cognate receptor (CCR8), which is highly specific for I-309, on these cells. To test for CCR8 gene expression, further Northern blot analyses were performed. As Figure 4 shows, CCR8 transcripts are present in high abundance in all ATL-derived cells tested. To obtain further proof for an antiapoptotic autocrine action of I-309, the chemokine signaling was suppressed in PaBe ATL cells that had been treated with monoclonal anti-Fas antibodies to undergo apoptosis (Figure 5).64 Increasing the concentration of Fas antibodies resulted in reduced [3H]-thymidine incorporation in ATL (PaBe) and Tax-immortalized (TAXI-1) cells, which is due to an increased apoptosis rate within the culture.65 The level of apoptosis increased with antibody concentrations between 0 and 100 ng/mL and reached a plateau at more than 100 ng/mL, indicating a partial resistance of these cells to apoptosis. This is in good agreement with previous studies.66 At the highest anti-Fas concentration of 500 ng/mL, cell proliferation of both ATL and TAXI-1 cells was reduced by only 39% compared with untreated cells (Figure 5A). However, in the presence of anti-I-309 antibodies the proliferation of the ATL cells was further decreased to 55%, whereas the control (TAXI-1) was unaffected. Similar results were obtained with Champ ATL cells. In contrast, the addition of isotype-matched control antibody did not influence cell growth. The corresponding proliferation rate was identical with the one obtained in the absence of antibody. Interestingly, even in the absence of external apoptotic signals, the anti-I-309 antibodies alone diminished cell proliferation by some 6% (Figure 5A, 0 µg/mL anti-Fas, + anti-I-309 antibody). A triple combination of anti-Fas, anti-I-309, and pertussis toxin did not substantially change the rate of cell proliferation. The moderate additional reduction in cell proliferation is probably due to pertussis toxin-mediated inhibition of I-309 signaling triggered by intracellular ligand-receptor interaction. Thus, this observation also supports the notion that interference with the I-309 receptor and no other G-protein-coupled receptor had caused the reduced cell proliferation. To specifically determine apoptosis, annexin V staining was applied, which detects a marker of early apoptosis.67 This analysis revealed that Fas-induced apoptosis in Mondi and TAXI-1 control cells remained unchanged in the presence of I-309-specific antibodies (Figure 5B and data not shown). In contrast, the anti-I-309 antibodies increased early apoptosis in ATL (PaBe) cells (Figure 5B). Together these data corroborate an autocrine antiapoptotic effect of I-309 in the presence of external apoptotic stimuli.
The high level of I-309 might counteract not only external but also
internal proapoptotic stimuli. To elucidate this possibility, ATL cells
(JuanaW) were incubated with increasing concentrations of pertussis
toxin. As shown in Figure 6A the drug
inhibited the proliferation of JuanaW cells in a dose-dependent manner;
at the highest pertussis toxin concentration, cell proliferation was reduced by more than 50%. Similar results were obtained with PaBe and
Champ ATL-derived cells (data not shown). In contrast, the proliferation of both CD4+ control cell lines, HuT-78
(T-ALL) and MT-2 (HTLV-1-transformed), was not affected. This
indicates that pertussis toxin has no unspecific cytotoxic effect on
uninfected and HTLV-1-infected T cells. To verify that the reduced
proliferation was due to apoptosis, DNA contents of pertussis
toxin-treated cells were determined by a modified PI staining assay
that allows the simultaneous distinction of viable, apoptotic, and
necrotic cells (Figure 6B).53 These analyses showed that
pertussis toxin significantly increased apoptosis, whereas necrosis was
only minimally affected. These results were confirmed by annexin V
staining (Figure 6C). Hence, all 3 assays demonstrate that pertussis
toxin induced apoptosis in ATL cells and, therefore, suggest a role for
I-309 signaling in counteracting inherent apoptosis. Taken together,
the autocrine antiapoptotic CCR8/I-309 signaling may stimulate the
proliferation of ATL cells by rendering the leukemic cells less
susceptible to internal and external apoptotic signals.
To link lymphocyte genes to HTLV-1-induced leukemogenesis, we
have identified several overexpressed mRNAs in cultured ATL cells. Many
of the corresponding proteins have functions in signal transduction and
could, thus, play a role in deregulated proliferation of the malignant
cells. Up-regulated genes included the dual-specific protein
phosphatase PAC1, the bHLH-transcription factor DEC-1, and the TNF- The overexpression of the ISG15 and I-309 genes
could only be found in JuanaW and other ATL-derived cell cultures.
ISG15, a 15-kd protein encoded by an interferon Four of 4 ATL patient-derived cells expressed the protein at strongly
increased levels, but none of the in vitro HTLV-1-infected cell lines
did so. This restricted expression pattern suggests that I-309
overexpression is a characteristic of ATL cell cultures. Long-term
cultivation of one of the used lines indicated that I-309
overexpression can be maintained for a minimum of 2 years in
IL-2-dependent cultures. The overexpression of the I-309
gene exclusively in ATL cells indicates that viral functions including Tax alone are not sufficient to activate its transcription. However, Tax may contribute to the I-309 overexpression. This is supported by
the notion that Tax stimulates the IL-1 gene,73
which is required for I-309 gene expression.72
Furthermore, the murine homologue (TCA3) carries a NF- The chemokine I-309 and its murine homologue TCA3 were both initially identified in T cells that had been restimulated after a history of previous activation.62,75 I-309 is a member of the family of CC chemokines, which contains 2 disulfide bonds at the N terminus. As a structural peculiarity, I-309 displays a third well-separated disulfide bond.76 I-309, like many other chemokines, induces leukocyte migration. In contrast to all other members of the CC chemokine family, I-309 has an additional biologic function in apoptosis.50 In addition to I-309, all ATL-derived cultures expressed the gene for the cognate receptor, CCR8, a 7-transmembrane domain Gi-protein-coupled receptor.77-79 In contrast to most other chemokine receptors that exhibit a promiscuous binding property to various chemokines, only one high-affinity cellular ligand has been identified for CCR8 (I-309).80 Recently, several tumor viral proteins that bind to CCR8 have been identified.81-83 Both, the high selectivity to its cellular ligand and its function as a viral target indicate that this chemokine has a unique function. The I-309 protein secreted by our ATL cultures prevented apoptosis of heterologous T cells. The following observations suggest that it also acts on the producer cells and increases their resistance to apoptosis. First, the cognate receptor (CCR8) is expressed in these cells. Second, interference with I-309 signaling considerably augmented the proapoptotic Fas signals in ATL cell cultures. At least partially this autocrine I-309 signaling may be explained by intracellular binding of the ligand to its receptor, a phenomenon observed for various growth factors and cytokines previously.84-87 This is suggested by the moderate increase of apoptosis resulting from addition of pertussis toxin to anti-I-309 antibody-treated ATL cultures. The I-309-mediated counteraction to external proapoptotic stimuli may cooperate with the antiapoptotic function of the death antagonist Bcl-XL, which is up-regulated in ex vivo ATL samples,88 to increase the survival of leukemia cells.89 Both mechanisms may contribute to the high resistance of patients with ATL to chemotherapy. The large amounts of I-309 could not only prevent exogenously induced apoptosis but may also antagonize internal proapoptotic stimuli. This is suggested by our observation that pertussis toxin, an inhibitor of I-309 signaling, significantly increased apoptosis of ATL-derived cells. In summary, these data provide evidence that the CCR8/I-309 signaling may stimulate the proliferation of ATL cells by generating an antiapoptotic autocrine loop, which counteracts inherent apoptotic stimuli. In addition, CCR8/I-309 could render leukemic cells less susceptible to external apoptosis signals and could, hence, contribute to ATL progression.
The technical assistance of Elisabeth Derow and Daniel Romaker is greatly appreciated. We thank Kerstin Haller and Claudia Matteucci for helpful scientific discussions.
Submitted November 20, 2000; accepted April 9, 2001.
Supported by the Deutsche Forschungsgemeinschaft (SFB 466 Lymphoproliferation und virale Immundefizienz), by the Wilhelm Sander-Stiftung, and by HERN (HTLV European Research Network).
The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734.
Reprints: Ralph Grassmann, Institut für Klinische und Molekulare Virologie, Schlossgarten 4, D-91054 Erlangen, Germany; e-mail: grassmann{at}viro.med.uni-erlangen.de.
1.
Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC.
Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.
Proc Natl Acad Sci U S A.
1980;77:7415-7419
2.
Seiki M, Hattori S, Hirayama Y, Yoshida M.
Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA.
Proc Natl Acad Sci U S A.
1983;80:3618-3622 3. Blattner WA. Human retroviruses: their role in cancer. Proc Assoc Am Physicians. 1999;111:563-572[CrossRef][Medline] [Order article via Infotrieve]. 4. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med. 2000;18:109-119[CrossRef][Medline] [Order article via Infotrieve]. 5. Grassmann R, Fleckenstein B, Desrosiers RC. Viral transformation of human T lymphocytes. Adv Cancer Res. 1994;63:211-244[Medline] [Order article via Infotrieve]. 6. Maruyama K, Fukushima T, Kawamura K, Mochizuki S. Chromosome and gene rearrangements in immortalized human lymphocytes infected with human T-lymphotropic virus type I. Cancer Res. 1990;50:5697S-5702S.
7.
Kamada N, Sakurai M, Miyamoto K, et al.
Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report.
Cancer Res.
1992;52:1481-1493 8. Miyake H, Suzuki T, Hirai H, Yoshida M. Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. Virology. 1999;253:155-161[CrossRef][Medline] [Order article via Infotrieve]. 9. Cavrois M, Leclercq I, Gout O, Gessain A, Wain-Hobson S, Wattel E. Persistent oligoclonal expansion of human T-cell leukemia virus type 1infected circulating cells in patients with tropical spastic paraparesis/HTLV-1 associated myelopathy. Oncogene. 1998;17:77-82[CrossRef][Medline] [Order article via Infotrieve]. 10. Gessain A. Virological aspects of tropical spastic paraparesis/HTLV-I associated myelopathy and HTLV-I infection. J Neurovirol. 1996;2:299-306[Medline] [Order article via Infotrieve]. 11. Izumo S, Umehara F, Osame M. HTLV-I-associated myelopathy. Neuropathology. 2000;20(suppl):S65-S68.
12.
Jeffery KJ, Usuku K, Hall SE, et al.
HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy.
Proc Natl Acad Sci U S A.
1999;96:3848-3853 13. Hidaka M, Inoue J, Yoshida M, Seiki M. Post-transcriptional regulator (Rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J. 1988;7:519-523[Medline] [Order article via Infotrieve]. 14. Grone M, Koch C, Grassmann R. The HTLV-1 Rex protein induces nuclear accumulation of unspliced viral RNA by avoiding intron excision and degradation. Virology. 1996;218:316-325[CrossRef][Medline] [Order article via Infotrieve]. 15. Ciminale V, D'Agostino DM, Zotti L, Chieco-Bianchi L. Coding potential of the X region of human T-cell leukemia/lymphotropic virus type II. J AIDS Hum Retrovirol. 1996;13(suppl 1):S220-S227. 16. Van Orden K, Yan JP, Ulloa A, Nyborg JK. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene. 1999;18:3766-3772[CrossRef][Medline] [Order article via Infotrieve]. 17. Lenzmeier BA, Baird EE, Dervan PB, Nyborg JK. The tax protein-DNA interaction is essential for HTLV-I transactivation in vitro. J Mol Biol. 1999;291:731-744[CrossRef][Medline] [Order article via Infotrieve].
18.
Tang Y, Tie F, Boros I, Harrod R, Glover M, Giam CZ.
An extended alpha-helix and specific amino acid residues opposite the DNA-binding surface of the cAMP response element binding protein basic domain are important for human T cell lymphotropic retrovirus type I Tax binding.
J Biol Chem.
1998;273:27339-27346 19. Mesnard JM, Devaux C. Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 Tax protein. Virology. 1999;257:277-284[CrossRef][Medline] [Order article via Infotrieve].
20.
Grassmann R, Berchtold S, Radant I, et al.
Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture.
J Virol.
1992;66:4570-4575
21.
Akagi T, Shimotohno K.
Proliferative response of Tax1-transduced primary human T cells to anti-CD3 antibody stimulation by an interleukin-2-independent pathway.
J Virol.
1993;67:1211-1217
22.
Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ, Ratner L.
Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.
Proc Natl Acad Sci U S A.
1995;92:1057-1061
23.
Hollsberg P.
Mechanisms of T-cell activation by human T-cell lymphotropic virus type I.
Microbiol Mol Biol Rev.
1999;63:308-333
24.
Schmitt I, Rosin O, Rohwer P, Gossen M, Grassmann R.
Stimulation of cyclin-dependent kinase activity and G1- to S-phase transition in human lymphocytes by the human T-cell leukemia/lymphotropic virus type 1 Tax protein.
J Virol.
1998;72:633-640 25. Jin DY, Spencer F, Jeang KT. Human T cell leukemia virus type 1 oncoprotein Tax targets the human mitotic checkpoint protein MAD1. Cell. 1998;93:81-91[CrossRef][Medline] [Order article via Infotrieve]. 26. Neuveut C, Jeang KT. HTLV-I Tax and cell cycle progression. Prog Cell Cycle Res. 2000;4:157-162[Medline] [Order article via Infotrieve]. 27. Suzuki T, Narita T, Uchida-Toita M, Yoshida M. Down-regulation of the INK4 family of cyclin-dependent kinase inhibitors by tax protein of HTLV-1 through two distinct mechanisms. Virology. 1999;259:384-391[CrossRef][Medline] [Order article via Infotrieve]. 28. Haller K, Ruckes T, Schmitt I, Saul D, Derow E, Grassmann R. Tax-dependent stimulation of G1 phase-specific cyclin-dependent kinases and increased expression of signal transduction genes characterize HTLV type 1-transformed T cells. AIDS Res Hum Retroviruses. 2000;16:1683-1688[CrossRef][Medline] [Order article via Infotrieve].
29.
Mulloy JC, Kislyakova T, Cereseto A, et al.
Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain.
J Virol.
1998;72:8852-8860
30.
Pise-Masison CA, Choi KS, Radonovich M, Dittmer J, Kim SJ, Brady JN.
Inhibition of p53 transactivation function by the human T-cell lymphotropic virus type 1 Tax protein.
J Virol.
1998;72:1165-1170
31.
Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G.
Cyclin D1 is a nuclear protein required for cell cycle progression in G1.
Genes Dev.
1993;7:812-821
32.
van den Heuvel S, Harlow E.
Distinct roles for cyclin-dependent kinases in cell cycle control.
Science.
1993;262:2050-2054
33.
Kao SY, Marriott SJ.
Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein.
J Virol.
1999;73:4299-4304
34.
Fujii M, Sassone-Corsi P, Verma IM.
c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.
Proc Natl Acad Sci U S A.
1988;85:8526-8530 35. Niewiesk S, Daenke S, Parker CE, et al. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J Virol. 1995;69:2649-2653[Abstract]. 36. Marriott SJ, Trinh D, Brady JN. Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: a potential role in HTLV-I pathogenesis. Oncogene. 1992;7:1749-1755[Medline] [Order article via Infotrieve]. 37. Inoue J, Seiki M, Taniguchi T, Tsuru S, Yoshida M. Induction of interleukin 2 receptor gene expression by p40x encoded by human T-cell leukemia virus type 1. EMBO J. 1986;5:2883-2888[Medline] [Order article via Infotrieve]. 38. Cross SL, Feinberg MB, Wolf JB, Holbrook NJ, Wong-Staal F, Leonard WJ. Regulation of the human interleukin-2 receptor alpha chain promoter: activation of a nonfunctional promoter by the transactivator gene of HTLV-I. Cell. 1987;49:47-56[CrossRef][Medline] [Order article via Infotrieve]. 39. Yoshida M, Suzuki T, Fujisawa J, Hirai H. HTLV-1 oncoprotein Tax and cellular transcription factors. Curr Top Microbiol Immunol. 1995;193:79[Medline] [Order article via Infotrieve]. 40. Baba M, Imai T, Yoshida T, Yoshie O. Constitutive expression of various chemokine genes in human T-cell lines infected with human T-cell leukemia virus type 1: role of the viral transactivator Tax. Int J Cancer. 1996;66:124-129[CrossRef][Medline] [Order article via Infotrieve].
41.
Santiago F, Clark E, Chong S, et al.
Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells.
J Virol.
1999;73:9917-9927 42. Akagi T, Ono H, Shimotohno K. Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1/Cip1/Sdi1. Oncogene. 1996;12:1645-1652[Medline] [Order article via Infotrieve].
43.
Cereseto A, Diella F, Mulloy JC, et al.
p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells.
Blood.
1996;88:1551-1560
44.
Jeang KT, Widen SG, Semmes OJ, Wilson SH.
HTLV-I trans-activator protein, Tax, is a trans-repressor of the human beta-polymerase gene.
Science.
1990;247:1082-1084 45. Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of bax gene expression by the HTLV-1 Tax protein: implications for suppression of apoptosis in virally infected cells. Virology. 1997;231:135-140[CrossRef][Medline] [Order article via Infotrieve]. 46. Harhaj EW, Good L, Xiao G, Sun SC. Gene expression profiles in HTLV-I-immortalized T cells: deregulated expression of genes involved in apoptosis regulation. Oncogene. 1999;18:1341-1349[CrossRef][Medline] [Order article via Infotrieve]. 47. Bex F, Gaynor RB. Regulation of gene expression by HTLV-I Tax protein. Methods. 1998;16:83-94[CrossRef][Medline] [Order article via Infotrieve].
48.
Diatchenko L, Lau YF, Campbell AP, et al.
Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries.
Proc Natl Acad Sci U S A.
1996;93:6025-6030
49.
Rosin O, Koch C, Schmitt I, Semmes OJ, Jeang KT, Grassmann R.
A human T-cell leukemia virus Tax variant incapable of activating NF- kappaB retains its immortalizing potential for primary T-lymphocytes.
J Biol Chem.
1998;273:6698-6703 50. Van Snick J, Houssiau F, Proost P, Van Damme J, Renauld JC. I-309/T cell activation gene-3 chemokine protects murine T cell lymphomas against dexamethasone-induced apoptosis. J Immunol. 1996;157:2570-2576[Abstract].
51.
Derfuss T, Fickenscher H, Kraft MS, et al.
Antiapoptotic activity of the herpesvirus saimiri-encoded Bcl-2 homolog: stabilization of mitochondria and inhibition of caspase-3-like activity.
J Virol.
1998;72:5897-5904 52. Maluish AE, Strong DM. Lymphocyte proliferation. In: Rose NR,de Macario EC,Folds JD,Lane HC,Nakamura RM, eds. ). Manual of Clinical Immunology. Washington, DC: American Society for Microbiology; 1986:274-281. 53. Matteucci C, Grelli S, De Smaele E, Fontana C, Mastino A. Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry. Cytometry. 1999;35:145-153[CrossRef][Medline] [Order article via Infotrieve].
54.
Shirono K, Hattori T, Hata H, Nishimura H, Takatsuki K.
Profiles of expression of activated cell antigens on peripheral blood and lymph node cells from different clinical stages of adult T-cell leukemia.
Blood.
1989;73:1664-1671
55.
Shimamura R, Kudo J, Kondo H, et al.
Expression of the thymosin beta 4 gene during differentiation of hematopoietic cells.
Blood.
1990;76:977-984 56. Shen M, Kawamoto T, Yan W, et al. Molecular characterization of the novel basic helix-loop-helix protein DEC1 expressed in differentiated human embryo chondrocytes. Biochem Biophys Res Commun. 1997;236:294-298[CrossRef][Medline] [Order article via Infotrieve].
57.
Wolf FW, Sarma V, Seldin M, et al.
B94, a primary response gene inducible by tumor necrosis factor-alpha, is expressed in developing hematopoietic tissues and the sperm acrosome.
J Biol Chem.
1994;269:3633-3640 58. Yi H, Morton CC, Weremowicz S, McBride OW, Kelly K. Genomic organization and chromosomal localization of the DUSP2 gene, encoding a MAP kinase phosphatase, to human 2p11.2-q11. Genomics. 1995;28:92-96[CrossRef][Medline] [Order article via Infotrieve].
59.
Blomstrom DC, Fahey D, Kutny R, Korant BD, Knight E Jr.
Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence.
J Biol Chem.
1986;261:8811-8816 60. Cosenza SC, Carter R, Pena A, et al. Growth-associated gene expression is not constant in cells traversing G-1 after exiting mitosis. J Cell Physiol. 1991;147:231-241[CrossRef][Medline] [Order article via Infotrieve]. 61. Thomson AM, Rogers JT, Leedman PJ. Iron-regulatory proteins, iron-responsive elements and ferritin mRNA translation. Int J Biochem Cell Biol. 1999;31:1139-1152[CrossRef][Medline] [Order article via Infotrieve]. 62. Miller MD, Hata S, De Waal MR, Krangel MS. A novel polypeptide secreted by activated human T lymphocytes. J Immunol. 1989;143:2907-2916[Abstract].
63.
Quandt K, Frech K, Karas H, Wingender E, Werner T.
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.
Nucleic Acids Res.
1995;23:4878-4884 64. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66:233-243[CrossRef][Medline] [Order article via Infotrieve].
65.
Debatin KM, Goldman CK, Waldmann TA, Krammer PH.
APO-1-induced apoptosis of leukemia cells from patients with adult T- cell leukemia.
Blood.
1993;81:2972-2977 66. Yamada Y, Sugahara K, Tsuruda K, et al. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production. Cancer Lett. 1999;147:215-219[CrossRef][Medline] [Order article via Infotrieve].
67.
Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH.
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.
Blood.
1994;84:1415-1420
68.
Wheat WH, Roesler WJ, Klemm DJ.
Simian virus 40 small tumor antigen inhibits dephosphorylation of protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation.
Mol Cell Biol.
1994;14:5881-5890 69. Sarma V, Wolf FW, Marks RM, Shows TB, Dixit VM. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J Immunol. 1992;148:3302-3312[Abstract]. 70. D'Cunha J, Ramanujam S, Wagner RJ, Witt PL, Knight E Jr, Borden E. In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol. 1996;157:4100-4108[Abstract]. 71. Yamada Y, Ohmoto Y, Hata T, et al. Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma. 1996;21:443-447[Medline] [Order article via Infotrieve]. 72. Selvan RS, Zhou LJ, Krangel MS. Regulation of I-309 gene expression in human monocytes by endogenous interleukin-1. Eur J Immunol. 1997;27:687-694[Medline] [Order article via Infotrieve].
73.
Mori N, Shirakawa F, Saito K, Murakami S, Oda S, Eto S.
Transactivation of the interleukin-1 alpha gene promoter by human T- cell leukemia virus type I tax in T cells [letter].
Blood.
1994;84:1688 74. Oh CK, Metcalfe DD. Transcriptional regulation of the TCA3 gene in mast cells after Fc epsilon RI cross-linking. J Immunol. 1994;153:325-332[Abstract]. 75. Burd PR, Freeman GJ, Wilson SD, et al. Cloning and characterization of a novel T cell activation gene. J Immunol. 1987;139:3126-3131[Abstract]. 76. Keizer DW, Crump MP, Lee TW, Slupsky CM, Clark-Lewis I, Sykes BD. Human CC chemokine I-309, structural consequences of the additional disulfide bond. Biochemistry. 2000;39:6053-6059[CrossRef][Medline] [Order article via Infotrieve]. 77. Napolitano M, Zingoni A, Bernardini G, et al. Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues. J Immunol. 1996;157:2759-2763[Abstract].
78.
Roos RS, Loetscher M, Legler DF, Clark-Lewis I, Baggiolini M, Moser B.
Identification of CCR8, the receptor for the human CC chemokine I-309.
J Biol Chem.
1997;272:17251-17254
79.
Tiffany HL, Lautens LL, Gao JL, et al.
Identification of CCR8: a human monocyte and thymus receptor for the CC chemokine I-309.
J Exp Med.
1997;186:165-170
80.
Goya I, Gutierrez J, Varona R, Kremer L, Zaballos A, Marquez G.
Identification of CCR8 as the specific receptor for the human beta-chemokine I-309: cloning and molecular characterization of murine CCR8 as the receptor for TCA-3.
J Immunol.
1998;160:1975-1981
81.
Dairaghi DJ, Fan RA, McMaster BE, Hanley MR, Schall TJ.
HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines.
J Biol Chem.
1999;274:21569-21574
82.
Luttichau HR, Stine J, Boesen TP, et al.
A highly selective CC chemokine receptor (CCR)8 antagonist encoded by the poxvirus Molluscum contagiosum.
J Exp Med.
2000;191:171-180 83. Napolitano M, Santoni A. Structure and function of the CC chemokine receptor (CCR) 8. Forum (Genova). 1999;9:315-324[Medline] [Order article via Infotrieve].
84.
Dunbar CE, Browder TM, Abrams JS, Nienhuis AW.
COOH-terminal-modified interleukin-3 is retained intracellularly and stimulates autocrine growth.
Science.
1989;245:1493-1496 85. Browder TM, Dunbar CE, Nienhuis AW. Private and public autocrine loops in neoplastic cells. Cancer Cells. 1989;1:9-17[Medline] [Order article via Infotrieve]. 86. Harsh GR, Keating MT, Escobedo JA, Williams LT. Platelet derived growth factor (PDGF) autocrine components in human tumor cell lines. J Neurooncol. 1990;8:1-12[CrossRef][Medline] [Order article via Infotrieve]. 87. Mitjavila MT, Le Couedic JP, Casadevall N, et al. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro. J Clin Invest 1991;88:789-797.
88.
Nicot C, Mahieux R, Takemoto S, Franchini G.
Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.
Blood.
2000;96:275-281
89.
Tsukahara T, Kannagi M, Ohashi T, et al.
Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-kappaB in apoptosis-resistant T-cell transfectants with Tax.
J Virol.
1999;73:7981-7987
© 2001 by The American Society of Hematology.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
 |
|
  A. Kawaguchi, Y. Orba, T. Kimura, H. Iha, M. Ogata, T. Tsuji, A. Ainai, T. Sata, T. Okamoto, W. W. Hall, et al. Inhibition of the SDF-1{alpha}-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice Blood, October 1, 2009; 114(14): 2961 - 2968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Baba, M. Okamoto, T. Hamasaki, S. Horai, X. Wang, Y. Ito, Y. Suda, and N. Arima Highly Enhanced Expression of CD70 on Human T-Lymphotropic Virus Type 1-Carrying T-Cell Lines and Adult T-Cell Leukemia Cells J. Virol., April 15, 2008; 82(8): 3843 - 3852. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Hieshima, D. Nagakubo, T. Nakayama, A.-K. Shirakawa, Z. Jin, and O. Yoshie Tax-Inducible Production of CC Chemokine Ligand 22 by Human T Cell Leukemia Virus Type 1 (HTLV-1)-Infected T Cells Promotes Preferential Transmission of HTLV-1 to CCR4-Expressing CD4+ T Cells J. Immunol., January 15, 2008; 180(2): 931 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Brown, M. Bellon, and C. Nicot Emodin and DHA potently increase arsenic trioxide interferon-{alpha}-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1 Blood, February 15, 2007; 109(4): 1653 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Soler, T. R. Chapman, L. R. Poisson, L. Wang, J. Cote-Sierra, M. Ryan, A. McDonald, S. Badola, E. Fedyk, A. J. Coyle, et al. CCR8 Expression Identifies CD4 Memory T Cells Enriched for FOXP3+ Regulatory and Th2 Effector Lymphocytes J. Immunol., November 15, 2006; 177(10): 6940 - 6951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. N'Diaye, E. Le Ferrec, D. Lagadic-Gossmann, S. Corre, D. Gilot, V. Lecureur, P. Monteiro, C. Rauch, M.-D. Galibert, and O. Fardel Aryl Hydrocarbon Receptor- and Calcium-dependent Induction of the Chemokine CCL1 by the Environmental Contaminant Benzo[a]pyrene J. Biol. Chem., July 21, 2006; 281(29): 19906 - 19915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Waldele, K. Silbermann, G. Schneider, T. Ruckes, B. R. Cullen, and R. Grassmann Requirement of the human T-cell leukemia virus (HTLV-1) tax-stimulated HIAP-1 gene for the survival of transformed lymphocytes Blood, June 1, 2006; 107(11): 4491 - 4499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Krueger, S. C. Fas, M. Giaisi, M. Bleumink, A. Merling, C. Stumpf, S. Baumann, D. Holtkotte, V. Bosch, P. H. Krammer, et al. HTLV-1 Tax protects against CD95-mediated apoptosis by induction of the cellular FLICE-inhibitory protein (c-FLIP) Blood, May 15, 2006; 107(10): 3933 - 3939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gombert, M.-C. Dieu-Nosjean, F. Winterberg, E. Bunemann, R. C. Kubitza, L. Da Cunha, A. Haahtela, S. Lehtimaki, A. Muller, J. Rieker, et al. CCL1-CCR8 Interactions: An Axis Mediating the Recruitment of T Cells and Langerhans-Type Dendritic Cells to Sites of Atopic Skin Inflammation J. Immunol., April 15, 2005; 174(8): 5082 - 5091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shimauchi, S. Imai, R. Hino, and Y. Tokura Production of Thymus and Activation-Regulated Chemokine and Macrophage-Derived Chemokine by CCR4+ Adult T-Cell Leukemia Cells Clin. Cancer Res., March 15, 2005; 11(6): 2427 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Qu, E. W. Edwards, F. Tacke, V. Angeli, J. Llodra, G. Sanchez-Schmitz, A. Garin, N. S. Haque, W. Peters, N. van Rooijen, et al. Role of CCR8 and Other Chemokine Pathways in the Migration of Monocyte-derived Dendritic Cells to Lymph Nodes J. Exp. Med., November 15, 2004; 200(10): 1231 - 1241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Waldele, G. Schneider, T. Ruckes, and R. Grassmann Interleukin-13 Overexpression by Tax Transactivation: a Potential Autocrine Stimulus in Human T-Cell Leukemia Virus-Infected Lymphocytes J. Virol., June 15, 2004; 78(12): 6081 - 6090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Schaerli, L. Ebert, K. Willimann, A. Blaser, R. S. Roos, P. Loetscher, and B. Moser A Skin-selective Homing Mechanism for Human Immune Surveillance T Cells J. Exp. Med., May 3, 2004; 199(9): 1265 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Rao, M. P. Quinones, E. Garavito, Y. Kalkonde, F. Jimenez, C. Gibbons, J. Perez, P. Melby, W. Kuziel, R. L. Reddick, et al. CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease J. Immunol., November 1, 2003; 171(9): 4875 - 4885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Qiuping, L. Qun, H. Chunsong, Z. Xiaolian, H. Baojun, Y. Mingzhen, L. Chengming, H. Jinshen, G. Qingping, Z. Kejian, et al. Selectively Increased Expression and Functions of Chemokine Receptor CCR9 on CD4+ T Cells from Patients with T-Cell Lineage Acute Lymphocytic Leukemia Cancer Res., October 1, 2003; 63(19): 6469 - 6477. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ishida, A. Utsunomiya, S. Iida, H. Inagaki, Y. Takatsuka, S. Kusumoto, G. Takeuchi, S. Shimizu, M. Ito, H. Komatsu, et al. Clinical Significance of CCR4 Expression in Adult T-Cell Leukemia/Lymphoma: Its Close Association with Skin Involvement and Unfavorable Outcome Clin. Cancer Res., September 1, 2003; 9(10): 3625 - 3634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Spinetti, G. Bernardini, G. Camarda, A. Mangoni, A. Santoni, M. C. Capogrossi, and M. Napolitano The chemokine receptor CCR8 mediates rescue from dexamethasone-induced apoptosis via an ERK-dependent pathway J. Leukoc. Biol., January 1, 2003; 73(1): 201 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Pise-Masison, M. Radonovich, R. Mahieux, P. Chatterjee, C. Whiteford, J. Duvall, C. Guillerm, A. Gessain, and J. N. Brady Transcription Profile of Cells Infected with Human T-cell Leukemia Virus Type I Compared with Activated Lymphocytes Cancer Res., June 1, 2002; 62(12): 3562 - 3571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Haller, Y. Wu, E. Derow, I. Schmitt, K.-T. Jeang, and R. Grassmann Physical Interaction of Human T-Cell Leukemia Virus Type 1 Tax with Cyclin-Dependent Kinase 4 Stimulates the Phosphorylation of Retinoblastoma Protein Mol. Cell. Biol., May 15, 2002; 22(10): 3327 - 3338. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
||
| Copyright © 2001 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||
Top
Abstract
Introduction
T-cell lines (Jurkat,
HuT-78, Molt-4), the HTLV-1+ T-cell lines (C91-PL, MT-2,
HuT-102), and the Tax-immortalized T-cell line (TAXI-1) were cultured
as previously described.
; Champ, 
; JuanaW, 
; StEd,
) in the BW5147C/DEX cells. MT-2 (×) and Jurkat (
) cell culture
supernatants served as negative controls. (B) Abrogation of the
antiapoptotic effect of the JuanaW cell culture supernatant in
BW5147C/DEX cells by the addition of pertussis toxin (2.5 ng/mL) 
/+
anti-Fas) and in the absence (
(IFN-